Skip to main content

Table 1 Hemagglutinin cleavage site and NAI resistance marker in wild-type viruses and CVVs

From: Development of high-growth influenza H7N9 prepandemic candidate vaccine viruses in suspension MDCK cells

CVVs

Wild-type viruses

Pathogenicity

Modification of hemagglutinin cleavage site

Modification of NAI resistance marker (R292K)

Wild type

CVVs

Wild type

CVVs

NHRI-RG3

A/Guangdong/17SF003/2016

HPAI

PEVPKRKRTAR/GLF

PEVPKGR/GLF

K

R

NHRI-RG4

A/Hong Kong/125/2017

LPAI

PEIPKGR/GLF

PEIPKGR/GLF

R

R

NHRI-RG5

A/Guangdong/SP440/2017

HPAI

PEVPKRKRTAR/GLF

PEVPKGR/GLF

K

R

NHRI-RG6

A/Taiwan/1/2017

HPAI

PEVPKRKRTAR/GLF

PEVPKGR/GLF

K

R

  1. Note: HPAI highly pathogenic avian influenza, LPAI low pathogenic avian influenza, NAI neuraminidase inhibitor